Literature DB >> 22236788

Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study.

Jay J K Siak1, Louis Tong, Wan Ling Wong, Howard Cajucom-Uy, Mohamad Rosman, Seang Mei Saw, Tien Yin Wong.   

Abstract

PURPOSE: To describe the prevalence and associations of meibomian gland dysfunction (MGD) in an urban Malay population in Singapore.
METHODS: Population-based cross-sectional study of 3280 (78.7% response rate) Malay persons aged 40 to 80 years, living in Singapore. MGD was defined by a slit-lamp clinical examination as either lid margin telangiectasia or meibomian gland orifice plugging in at least one eye. Participants underwent a standardized questionnaire and clinical examination, including laboratory investigations. Data were analyzed for 3271 persons.
RESULTS: The age-standardized prevalence of MGD was 56.3% [95% confidence interval (CI), 53.3-59.4]. A higher MGD prevalence was found in male participants across all age groups [odds ratio (OR), 1.30; 95% CI, 1.35-1.79], postmenopausal women (OR, 1.64; 95% CI, 1.19-2.33), and all participants with pinguecula (OR, 2.43; 95% CI, 2.08-2.85), high diastolic blood pressure (OR, 1.32; 95% CI, 1.08-1.62), and use of angiotensin II receptor blockers (OR, 4.02; 95% CI, 1.74-9.27).
CONCLUSIONS: MGD was highly prevalent in this Asian population and associated with various systemic and ocular conditions.

Entities:  

Mesh:

Year:  2012        PMID: 22236788     DOI: 10.1097/ICO.0b013e31823f0977

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  24 in total

1.  Are BALB/c Mice Relevant Models for Understanding Sex-Related Differences in Gene Expression in the Human Meibomian Gland?

Authors:  Xiaomin Chen; Benjamin D Sullivan; Raheleh Rahimi Darabad; Shaohui Liu; Wendy R Kam; David A Sullivan
Journal:  Cornea       Date:  2019-12       Impact factor: 2.651

Review 2.  Update on the role of impression cytology in ocular surface disease.

Authors:  Zhang-Zhe Thia; Louis Tong
Journal:  Taiwan J Ophthalmol       Date:  2019-09-12

3.  Meibomian gland dysfunction in geriatric population: tehran geriatric eye study.

Authors:  Hassan Hashemi; Amir Asharlous; Mohamadreza Aghamirsalim; Abbasali Yekta; Rama Pourmatin; Masoome Sajjadi; Mojgan Pakbin; Mohammadreza Asadollahi; Mehdi Khabazkhoob
Journal:  Int Ophthalmol       Date:  2021-03-24       Impact factor: 2.031

4.  Epidemiology of Meibomian Gland Dysfunction in an Elderly Population.

Authors:  Yousef A Alghamdi; Carolina Mercado; Allison L McClellan; Hatim Batawi; Carol L Karp; Anat Galor
Journal:  Cornea       Date:  2016-06       Impact factor: 2.651

Review 5.  Image-guided evaluation and monitoring of treatment response in patients with dry eye disease.

Authors:  Yureeda Qazi; Shruti Aggarwal; Pedram Hamrah
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-04       Impact factor: 3.117

6.  Differential scanning calorimetric evaluation of human meibomian gland secretions and model lipid mixtures: transition temperatures and cooperativity of melting.

Authors:  Hua Lu; Jadwiga C Wojtowicz; Igor A Butovich
Journal:  Chem Phys Lipids       Date:  2013-04-08       Impact factor: 3.329

7.  Association of Dry Eye Disease With Dyslipidemia and Statin Use.

Authors:  Khalid M Aldaas; Omar M Ismail; Judi Hakim; Eric D Van Buren; Feng-Chang Lin; Joshua S Hardin; Jay J Meyer
Journal:  Am J Ophthalmol       Date:  2020-05-12       Impact factor: 5.258

8.  Lost to follow-up for appointments in a dedicated dry eye clinic.

Authors:  Kip Hoe Poon; Sharon Yeo; Louis Tong
Journal:  Patient Prefer Adherence       Date:  2014-10-09       Impact factor: 2.711

9.  A Randomized, Controlled Treatment Trial of Eyelid-Warming Therapies in Meibomian Gland Dysfunction.

Authors:  Hui Shan Sim; Andrea Petznick; Sylvaine Barbier; Jen Hong Tan; U Rajendra Acharya; Sharon Yeo; Louis Tong
Journal:  Ophthalmol Ther       Date:  2014-08-26

10.  Intense pulsed light (IPL) therapy for the treatment of meibomian gland dysfunction.

Authors:  Sharlotta Cote; Alexis Ceecee Zhang; Victoria Ahmadzai; Amina Maleken; Christine Li; Jeremy Oppedisano; Kaavya Nair; Ljoudmila Busija; Laura E Downie
Journal:  Cochrane Database Syst Rev       Date:  2020-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.